News headlines about NanoString Technologies (NASDAQ:NSTG) have trended somewhat positive recently, Accern reports. Accern rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. NanoString Technologies earned a news impact score of 0.13 on Accern’s scale. Accern also assigned press coverage about the biotechnology company an impact score of 46.3492693064451 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

NSTG has been the topic of a number of research reports. Cowen reaffirmed a “buy” rating and issued a $20.00 price objective on shares of NanoString Technologies in a report on Thursday, September 28th. Janney Montgomery Scott lowered NanoString Technologies from a “buy” rating to a “neutral” rating in a report on Thursday, October 12th. Robert W. Baird decreased their price objective on NanoString Technologies from $23.00 to $19.00 and set an “outperform” rating on the stock in a report on Thursday, October 12th. Finally, Zacks Investment Research lowered NanoString Technologies from a “hold” rating to a “sell” rating in a report on Tuesday, October 17th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. NanoString Technologies presently has an average rating of “Hold” and a consensus target price of $15.06.

Shares of NanoString Technologies (NASDAQ:NSTG) traded up $0.17 during midday trading on Thursday, reaching $8.33. The company’s stock had a trading volume of 98,700 shares, compared to its average volume of 174,536. The company has a current ratio of 3.35, a quick ratio of 2.89 and a debt-to-equity ratio of 1.08. NanoString Technologies has a 52-week low of $7.03 and a 52-week high of $20.70. The firm has a market cap of $207.12, a price-to-earnings ratio of -4.02 and a beta of 0.82.

NanoString Technologies (NASDAQ:NSTG) last issued its quarterly earnings data on Thursday, November 2nd. The biotechnology company reported ($0.45) EPS for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.11. NanoString Technologies had a negative return on equity of 174.55% and a negative net margin of 44.24%. The firm had revenue of $27.02 million for the quarter, compared to analyst estimates of $26.27 million. During the same period in the prior year, the firm posted ($0.51) EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. research analysts expect that NanoString Technologies will post -1.81 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “NanoString Technologies (NSTG) Earns Daily Media Sentiment Rating of 0.13” was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.watchlistnews.com/nanostring-technologies-nstg-earns-daily-media-sentiment-rating-of-0-13/1812444.html.

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Insider Buying and Selling by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.